Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-03

Clinical Trial Update: A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 trial evaluating bile acid supplementation in progressive multiple sclerosis has been completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: Progressive Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-05-03